- Home
- QMCO vs VTYX Comparison
QMCO vs VTYX Comparison
Compare QMCO & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- VTYX
- Stock Information
- Founded
- QMCO 1980
- VTYX 2018
- Country
- QMCO United States
- VTYX United States
- Employees
- QMCO N/A
- VTYX N/A
- Industry
- QMCO Electronic Components
- VTYX Medicinal Chemicals and Botanical Products
- Sector
- QMCO Technology
- VTYX Health Care
- Exchange
- QMCO Nasdaq
- VTYX Nasdaq
- Market Cap
- QMCO 157.2M
- VTYX 154.9M
- IPO Year
- QMCO N/A
- VTYX 2021
- Fundamental
- Price
- QMCO $10.29
- VTYX $3.92
- Analyst Decision
- QMCO Hold
- VTYX Buy
- Analyst Count
- QMCO 2
- VTYX 3
- Target Price
- QMCO $19.00
- VTYX $10.00
- AVG Volume (30 Days)
- QMCO 3.1M
- VTYX 1.6M
- Earning Date
- QMCO 11-12-2025
- VTYX 11-06-2025
- Dividend Yield
- QMCO N/A
- VTYX N/A
- EPS Growth
- QMCO N/A
- VTYX N/A
- EPS
- QMCO N/A
- VTYX N/A
- Revenue
- QMCO $266,079,000.00
- VTYX N/A
- Revenue This Year
- QMCO N/A
- VTYX N/A
- Revenue Next Year
- QMCO $5.30
- VTYX N/A
- P/E Ratio
- QMCO N/A
- VTYX N/A
- Revenue Growth
- QMCO N/A
- VTYX N/A
- 52 Week Low
- QMCO $2.88
- VTYX $0.78
- 52 Week High
- QMCO $90.64
- VTYX $4.12
- Technical
- Relative Strength Index (RSI)
- QMCO 48.78
- VTYX 66.18
- Support Level
- QMCO $11.18
- VTYX $3.48
- Resistance Level
- QMCO $13.42
- VTYX $4.12
- Average True Range (ATR)
- QMCO 1.40
- VTYX 0.32
- MACD
- QMCO -0.15
- VTYX 0.03
- Stochastic Oscillator
- QMCO 13.21
- VTYX 85.22
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.